SCHEMBL5708372

SCHEMBL5708372

COc1ccc(Nc2ccc(CCN[C@H](O)Cc3ccc(O)c(NC=O)c3)cc2)cc1CCN

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 15/20 0.52
▸ ADRB1 P08588 13/20 0.52
▸ ADRB3 P13945 10/20 0.52
▸ DRD2 P14416 2/20 0.39
▸ PGR P06401 1/20 0.39
▸ SLC6A4 P31645 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ DRD3 P35462 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL775313 0.84 ADRB2 (0.73) ADRB2ADRB1ADRB3
SCHEMBL5708299 0.78 ADRB2 (0.72) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL5172235 0.76 ADRB2 (0.48) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL7182431 0.74 ADRB2 (0.56) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL5969790 0.71 ADRB2 (0.61) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL375931 0.70 ADRB2 (0.74) ADRB2ADRB1ADRB3
SCHEMBL5086743 0.70 ADRB2 (0.47) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL5968418 0.70 ADRB2 (0.59) ADRB2ADRB1ADRB3DRD2PGR
SCHEMBL775385 0.68 ADRB2 (0.77) ADRB2ADRB1ADRB3DRD2DRD3
SCHEMBL3843666 0.68 ADRB2 (1.00) ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706371-A1 ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS Theravance, Inc. (US) 2006-10-04 — — EP disclosed
WO-2005070872-A1 ARYL ANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEPTOR AGONISTS THERAVANCE, INC. (US) 2005-08-04 — — WO disclosed
Send feedback